A Blind, Randomized and Controlled Clinical Trial to Evaluate the Safety of Live Attenuated Varicella Vaccines for Healthy Adults, Adolescents and Children

Trial Profile

A Blind, Randomized and Controlled Clinical Trial to Evaluate the Safety of Live Attenuated Varicella Vaccines for Healthy Adults, Adolescents and Children

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2016

At a glance

  • Drugs Varicella zoster vaccine Sinovac Biotech (Primary)
  • Indications Varicella zoster virus infections
  • Focus Adverse reactions
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 19 Oct 2016 According to a Sinovac Biotech media release, status changed from active, no longer recruiting to completed.
    • 26 May 2016 Status changed from not yet recruiting to recruiting, as reported in a Sinovac Biotech media release.
    • 05 Apr 2016 According to a Sinovac Biotech media release, the clinical trials of varicella vaccine are expected to be launched in the first half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top